Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01738009 · ClinicalTrials.gov registry record · NA

Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study B

A NA study of Sleep Apnea, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT01738009 is a NA study of Sleep Apnea that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 40 participants, below the 2,988-participant average among 36 other Sleep Apnea trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01738009, a NA study of Sleep Apnea, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

In obstructive sleep apnea (OSA), the upper airway recurrently closes during sleep. The mechanisms that lead to airway closure are not completely understood. Some studies have shown that there is progressive narrowing of the pharyngeal airway across breaths during expiration (Progressive Expiratory Narrowing, PEN) preceding an obstructive apnea. The cause of PEN is unknown. The investigators will test if lung volumes and low respiratory drive play a role in PEN.

Conditions Studied

Interventions

  • OTHER Induction of flow limitation

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2012-12-08
Est. Completion 2016-10
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT01738009

The ClinicalTrials.gov registry entry for NCT01738009 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,988-participant average among 36 other Sleep Apnea trials with a reported enrollment target (99% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which Induction of flow limitation is the first listed.

NCT01738009 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01738009 about?

NCT01738009 is a clinical study titled "Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study B". In obstructive sleep apnea (OSA), the upper airway recurrently closes during sleep. The mechanisms that lead to airway closure are not completely understood. Some studies have shown that there is progressive narrowing of the pharyngeal airway across breaths during expiration (Progressive Expiratory ...

What is the current status of trial NCT01738009?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2012-12-08. Estimated completion is 2016-10.

What conditions does trial NCT01738009 study?

This clinical trial studies the following conditions: Sleep Apnea.

What interventions are being tested in trial NCT01738009?

The interventions under investigation include: Induction of flow limitation (OTHER).

Who is sponsoring clinical trial NCT01738009?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01738009 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.